thyroxine has been researched along with Local Neoplasm Recurrence in 111 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We aimed to evaluate the oncological impact of hypothyroidism and levothyroxine (LT) supplementation after hemithyroidectomy in patients with papillary thyroid carcinoma (PTC)." | 7.96 | Oncological impact of hypothyroidism and levothyroxine supplementation following hemithyroidectomy in patients with papillary thyroid carcinoma. ( Ahn, D; Jeon, JH; Lee, GJ; Sohn, JH, 2020) |
| " While this regimen effectively blocked adrenal function, it was complicated by a drug interaction in which aminoglutethimide accelerated the metabolism and reduced the bioavailability of dexamethasone." | 6.36 | Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer. ( Harvey, H; Kendall, J; Lipton, A; Ruby, EB; Samojlik, E; Santen, RJ; Wells, SA, 1977) |
| "Patients with differentiated thyroid carcinoma are commonly treated long-term with thyrotropin (TSH)-suppressive thyroxine replacement therapy, which lead to a state of subclinical hyperthyroidism." | 4.84 | [Effects of thyrotropin-suppressive therapy in patients with well-differentiated thyroid carcinoma]. ( Miyakawa, M, 2007) |
| " Recombinant TSH is comparable to hypothyroidism in the generation of Tg and in the execution of iodine-131 whole-body scanning, with the advantage of sparing patients from the symptoms of hypothyroidism and from impaired quality of life induced by levothyroxine withdrawal, in addition to a reduced exposure to elevated TSH and shorter absence from work, with recombinant TSH being the preparation indicated for the diagnosis of metastases in both low risk (Tg after recombinant TSH) and moderate or high risk patients (Tg and iodine-131 scanning after recombinant TSH)." | 4.82 | [Recombinant TSH in ablative therapy and follow-up of patients with differentiated thyroid carcinoma]. ( Barroso, AL; Fagundes, TA; Padrão, EL; Purisch, S; Rezende, LL; Rosário, PW, 2005) |
| "We aimed to evaluate the oncological impact of hypothyroidism and levothyroxine (LT) supplementation after hemithyroidectomy in patients with papillary thyroid carcinoma (PTC)." | 3.96 | Oncological impact of hypothyroidism and levothyroxine supplementation following hemithyroidectomy in patients with papillary thyroid carcinoma. ( Ahn, D; Jeon, JH; Lee, GJ; Sohn, JH, 2020) |
| "Thyroid function was measured by means of thyroid stimulating hormone (TSH), free thyroxine (FT4) and free triiodthyronine (FT3) in 43 patients who had nonthyroid head-neck carcinomas treated by radiotherapy or radiotherapy in combination with other modalities." | 3.80 | Hypothyroidism after radiotherapy of head and neck cancer. ( Bernát, L; Hrušák, D, 2014) |
| "4%) needed thyroxine treatment for post-operative hypothyroidism." | 3.80 | Nodular recurrence and hypothyroidism following partial thyroidectomy for benign nodular thyroid disease in children and adolescents. ( Akkari, M; Blanchet, C; Cartier, C; Garrel, R; Guerrier, B; Jeandel, C; Makeieff, M; Mondain, M; Raingeard, I; Schmitt, D, 2014) |
| "To determine the effect of levothyroxine (L-T4) therapy on the recurrence rate of nodular disease in patients previously treated with lobectomy for benign nodular goiter." | 3.75 | Levothyroxine therapy in preventing nodular recurrence after hemithyroidectomy: a retrospective study. ( Alba, M; Corsello, SM; Fintini, D; Lovicu, RM; Papi, G; Paragliola, RM; Pontecorvi, A; Rota, CA, 2009) |
| "Sixty-two metastases or recurrences of differentiated thyroid carcinomas were investigated using conventional histology and immunocytochemistry for thyroglobulin (TG), thyroxine (T4) and triiodothyronine (T3)." | 3.68 | Histology and immunocytochemistry of differentiated thyroid carcinomas do not predict radioiodine uptake: a clinicomorphological study of 62 recurrent or metastatic tumours. ( Bätge, B; Dralle, H; Padberg, B; Schröder, S; von Herbay, B, 1992) |
| "Serum 'free thyroxine' was measured as a thyroid function index (TFI) in 238 women with early breast cancer and 107 normal controls." | 3.66 | Thyroid function in early breast cancer. ( Bulbrook, RD; Hayward, JL; Millis, R; Russell, MJ; Thomas, BS, 1983) |
| "Familial non-autoimmune hyperthyroidism is a rare disease caused by germline activating variants in the thyroid-stimulating hormone receptor (TSHR) gene." | 2.72 | Novel presentation of the c.1856A > G (p.Asp619Gly) TSHR gene-activating variant: relapsing hyperthyroidism in three subsequent generations manifesting in early childhood and an in vitro functional study. ( Bezdicka, M; Borecka, M; El-Lababidi, E; Kleiblova, P; Malikova, J; Rataj, M; Smrz, D; Soucek, J; Soucek, O; Sumnik, Z, 2021) |
| "Differentiated thyroid cancer is the most common malignant carcinoma in female population." | 2.58 | [Advances in postoperative thyroid-stimulating hormone suppression therapy in females with thyroid cancer]. ( Song, F; Yi, HL, 2018) |
| "The management of nodules and thyroid cancer is evolving." | 2.53 | Advances in the management of differentiated thyroid cancer with follicular cell strain. ( Ben Ali, M; Ben Raies, N; Ben Slimène, F; Karboua, E; Mhiri, A; Schlumberger, M; Slimène, H, 2016) |
| "Primary therapy of thyroid cancer is an adequate surgery: total thyreoidectomy and, if necessary, lymph node dissection or limited surgery in selected cases." | 2.47 | [Differentiated thyroid cancer -- 2009]. ( Konrády, A, 2011) |
| "Thyroid carcinoma was detected in 3." | 2.44 | Appropriate treatment for asymptomatic papillary microcarcinoma of the thyroid. ( Ito, Y; Miyauchi, A, 2007) |
| "Papillary and follicular thyroid carcinomas are among the most curable of all cancers." | 2.41 | Papillary and follicular thyroid carcinoma. ( Schlumberger, MJ; Torlantano, M, 2000) |
| " While this regimen effectively blocked adrenal function, it was complicated by a drug interaction in which aminoglutethimide accelerated the metabolism and reduced the bioavailability of dexamethasone." | 2.36 | Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer. ( Harvey, H; Kendall, J; Lipton, A; Ruby, EB; Samojlik, E; Santen, RJ; Wells, SA, 1977) |
| " Individualized management and accurate hormone replacement dosage for postoperative childhood-onset CP patients are of great importance." | 1.91 | Postoperative hypothalamic-pituitary dysfunction and long-term hormone replacement in patients with childhood-onset craniopharyngioma. ( Bai, RN; Chen, J; Deng, Y; Fan, K; Ge, M; Gong, J; Li, S; Miao, Y; Peng, X; Wei, Y; Wu, D; Wu, Q; Zhao, C, 2023) |
| "Nodular goiter is the most common disorder of the thyroid gland." | 1.51 | Long-term sequelae of the less than total thyroidectomy procedures for benign thyroid nodular disease. ( Alexandraki, K; Boutzios, G; Garoufalia, Z; Kouraklis, G; Tsourouflis, G, 2019) |
| "Despite similar rates of recurrence (HR 1." | 1.42 | Thyrotropin suppression increases the risk of osteoporosis without decreasing recurrence in ATA low- and intermediate-risk patients with differentiated thyroid carcinoma. ( Boucai, L; Fagin, JA; Ganly, I; Mahrous, A; Nixon, IJ; Palmer, FL; Patel, SG; Smith, AW; Tuttle, RM; Wang, LY, 2015) |
| "Lateral lymph node metastasis is an important prognostic factor and is predictive of tumor recurrence and cause-specific survival in patients with papillary thyroid cancer (PTC)." | 1.40 | Risk factors for recurrence after therapeutic lateral neck dissection for primary papillary thyroid cancer. ( Chung, KW; Jung, YS; Kim, SJ; Kim, SK; Kim, TH; Lee, EK; Lee, YJ; Myong, JP; Park, SY; Ryu, J, 2014) |
| "In patients with differentiated thyroid cancer (DTC), the stimulated serum thyroglobulin (Tg) level at radioiodine ablation is a known predictive factor of persistent disease." | 1.40 | Stimulated thyroglobulin level at ablation in differentiated thyroid cancer: the impact of treatment preparation modalities and tumor burden. ( Bardet, S; Blanchard, D; Ciappuccini, R; de Raucourt, D; Hardouin, J; Heutte, N; Quak, E; Rame, JP; Vaur, D, 2014) |
| "A total of 102 patients with thyroid cancer who fulfilled the following criteria were studied: submitted to total thyroidectomy with complete tumor resection; tumor ≤4 cm without extrathyroid invasion or lymph node metastases; negative anti-thyroglobulin (anti-Tg) antibodies." | 1.38 | Recombinant human thyroid stimulating hormone in thyroid remnant ablation with 1.1 GBq 131iodine in low-risk patients. ( Rosario, PW; Xavier, AC, 2012) |
| "The best treatment option for recurrent papillary thyroid carcinoma (PTC) is reoperation when the recurrent lesion is locoregional." | 1.38 | Serum thyroglobulin level measured after thyroxine withdrawal is useful to predict further recurrence in whole body scan-negative papillary thyroid cancer patients after reoperation. ( Ahn, HY; Cho, BY; Choi, HS; Kim, KW; Kim, TH; Lee, EK; Lee, YJ; Lim, JA; Park, DJ; Park, YJ; Yi, KH, 2012) |
| "Thyroid MALT lymphoma is an extremely rare malignancy believed to arise against a background of Hashimoto's thyroiditis." | 1.37 | Transition of thyroid autoantibodies by rituximab treatment for thyroid MALT lymphoma. ( Ishikura, K; Iwaki, N; Kahara, T; Kaya, H; Kurokawa, T; Usuda, R; Yoshida, T, 2011) |
| "Six women had evidence of thyroid cancer progression during the first pregnancy; one of them also showed disease progression during a second pregnancy." | 1.36 | Impact of pregnancy on outcome and prognosis of survivors of papillary thyroid cancer. ( Benbassat, C; Grozinski-Glasberg, S; Hirsch, D; Levy, S; Lifshitz, A; Shimon, I; Shraga-Slutzky, I; Singer, J; Tsvetov, G; Weinstein, R, 2010) |
| "Serum thyroglobulin (Tg), a widely used thyroid cancer marker, is limited at the time of ablation, unable to differentiate between diseased and normal residual tissue." | 1.35 | Ablative free thyroxine to thyroglobulin ratio as a predictor of differentiated thyroid cancer recurrence. ( Aron, M; Black, MJ; Cote, V; Hier, M; Payne, RJ; Tamilia, M; Zhang, X, 2009) |
| "Diagnosis of a giant macroprolactinoma was made and cabergoline was started." | 1.35 | Misdiagnosis due to the hook effect in prolactin assay. ( Arda, N; Comlekci, A; Men, S; Yener, S; Yesil, S, 2008) |
| "Thyroid hormone therapy reduced recurrences in this irradiated cohort." | 1.34 | Factors related to the recurrence of thyroid nodules after surgery for benign radiation-related nodules. ( Collins, BJ; Schneider, AB; Subbiah, S, 2007) |
| "181 patients with well-differentiated thyroid cancer were surveyed using a thyroid-specific QOL-thyroid survey at three times throughout the study: prior to T4 withdrawal, after the 3-week withdrawal period, and 4 weeks after resuming T3/T4 combination therapy." | 1.33 | Three-week thyroxine withdrawal: a thyroid-specific quality of life study. ( Davids, T; Eski, S; Freeman, JL; Walfish, PG; Witterick, IJ, 2006) |
| "One liver metastasis could not be detected because of the physiologic tracer distribution of 99mTc-tetrofosmin." | 1.30 | Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma. ( Gallowitsch, HJ; Gomez, I; Kresnik, E; Lind, P; Mikosch, P; Unterweger, O, 1998) |
| " If thyroglobulin remains undetectable during L-thyroxine treatment, an annual dosage is indicated and other exams are unwarranted." | 1.30 | [Papillary and follicular cancers of the thyroid]. ( Baudin, E; Schlumberger, M; Travagli, JP, 1998) |
| "Patients with thyroid cancer are monitored for disease recurrence by measurement of serum thyroglobulin (Tg) and iodine-131 (131I) scanning." | 1.30 | Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma. ( Anderson, JS; Balducci-Silano, PL; Burman, KD; Francis, GL; Ladenson, PW; Levine, MA; Ringel, MD; Silverman, J; Sparling, YH; Spencer, CA; Tuttle, RM; Wartofsky, L, 1999) |
| " To find the target level of TSH suppression, we analyzed the relationship between the degree of TSH suppression determined by third generation assay and thyroglobulin (Tg) response during the titration of the dosage of L-T4." | 1.30 | Levothyroxine suppression of thyroglobulin in patients with differentiated thyroid carcinoma. ( Chen, HY; Chien, WY; Lee, CH; Liu, RT; Lu, YC; Tung, SC; Wang, PW; Wang, ST, 1999) |
| ""Occult" papillary carcinomas are characterized as small papillary tumors of less than 1." | 1.27 | Not all "occult" papillary carcinomas are "minimal". ( Allo, MD; Christianson, W; Koivunen, D, 1988) |
| "The non-surgical treatment of thyroid cancer is outlined." | 1.25 | The non-surgical treatment of thyroid cancer. ( Halnan, KE, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (8.11) | 18.7374 |
| 1990's | 18 (16.22) | 18.2507 |
| 2000's | 37 (33.33) | 29.6817 |
| 2010's | 37 (33.33) | 24.3611 |
| 2020's | 10 (9.01) | 2.80 |
| Authors | Studies |
|---|---|
| Meirovitz, A | 1 |
| Nisman, B | 2 |
| Allweis, TM | 2 |
| Carmon, E | 2 |
| Kadouri, L | 2 |
| Maly, B | 2 |
| Maimon, O | 2 |
| Peretz, T | 2 |
| Vasyliev, LY | 1 |
| Radzishevska, YB | 1 |
| Savchenko, AS | 1 |
| Vygivska, LA | 1 |
| Radzishevska, YK | 1 |
| Boiko, OM | 1 |
| Liu, Y | 1 |
| Huang, Y | 1 |
| Mo, G | 1 |
| Zhou, T | 1 |
| Hou, Q | 1 |
| Shi, C | 1 |
| Yu, J | 1 |
| Lv, Y | 1 |
| Waissengrin, B | 3 |
| Zahavi, T | 3 |
| Salmon-Divon, M | 3 |
| Goldberg, A | 3 |
| Wolf, I | 3 |
| Rubinek, T | 3 |
| Winkler, T | 3 |
| Farkash, O | 3 |
| Grinshpun, A | 3 |
| Zubkov, A | 3 |
| Khatib, M | 3 |
| Shachar, SS | 3 |
| Keren, N | 3 |
| Carmi-Levy, I | 3 |
| Ben-David, U | 3 |
| Sonnenblick, A | 3 |
| Hao, Y | 1 |
| Zhong, L | 1 |
| Miao, Y | 1 |
| Fan, K | 1 |
| Peng, X | 1 |
| Li, S | 1 |
| Chen, J | 1 |
| Bai, RN | 1 |
| Wei, Y | 1 |
| Deng, Y | 1 |
| Zhao, C | 1 |
| Wu, Q | 1 |
| Ge, M | 1 |
| Gong, J | 1 |
| Wu, D | 1 |
| Ahn, D | 1 |
| Lee, GJ | 1 |
| Sohn, JH | 1 |
| Jeon, JH | 1 |
| Feng, JW | 1 |
| Wu, WX | 1 |
| Hu, J | 1 |
| Hong, LZ | 1 |
| Qin, AC | 1 |
| Jiang, Y | 1 |
| Ye, J | 1 |
| Meierovich, A | 1 |
| Bezdicka, M | 1 |
| Kleiblova, P | 1 |
| Soucek, J | 1 |
| Borecka, M | 1 |
| El-Lababidi, E | 1 |
| Smrz, D | 1 |
| Rataj, M | 1 |
| Sumnik, Z | 1 |
| Malikova, J | 1 |
| Soucek, O | 1 |
| Khan, M | 1 |
| Syed, AA | 1 |
| Khan, AI | 1 |
| Hussain, SR | 1 |
| Urooj, N | 1 |
| Bellantone, R | 1 |
| Raffaelli, M | 1 |
| De Crea, C | 1 |
| Sessa, L | 1 |
| Traini, E | 1 |
| Princi, P | 1 |
| Lombardi, CP | 1 |
| Song, F | 1 |
| Yi, HL | 1 |
| Boutzios, G | 1 |
| Tsourouflis, G | 1 |
| Garoufalia, Z | 1 |
| Alexandraki, K | 1 |
| Kouraklis, G | 1 |
| Lee, MC | 1 |
| Kim, MJ | 1 |
| Choi, HS | 2 |
| Cho, SW | 1 |
| Lee, GH | 1 |
| Park, YJ | 2 |
| Park, DJ | 2 |
| Vasil'ev, DA | 1 |
| Poroshina, TE | 1 |
| Radzhabova, ZA | 1 |
| Bershteĭn, LM | 1 |
| Molinaro, E | 1 |
| Giani, C | 1 |
| Agate, L | 1 |
| Biagini, A | 1 |
| Pieruzzi, L | 1 |
| Bianchi, F | 1 |
| Brozzi, F | 1 |
| Ceccarelli, C | 1 |
| Viola, D | 1 |
| Piaggi, P | 1 |
| Vitti, P | 1 |
| Pacini, F | 4 |
| Elisei, R | 2 |
| Bauer, PS | 1 |
| Murray, S | 1 |
| Clark, N | 1 |
| Pontes, DS | 1 |
| Sippel, RS | 1 |
| Chen, H | 1 |
| Gagnon, A | 2 |
| Abujrad, H | 1 |
| Irobi, C | 1 |
| Lochnan, HA | 2 |
| Sorisky, A | 2 |
| Bernát, L | 1 |
| Hrušák, D | 1 |
| Kim, SJ | 1 |
| Park, SY | 1 |
| Lee, YJ | 2 |
| Lee, EK | 2 |
| Kim, SK | 1 |
| Kim, TH | 2 |
| Jung, YS | 1 |
| Ryu, J | 1 |
| Myong, JP | 1 |
| Chung, KW | 1 |
| Ciappuccini, R | 1 |
| Hardouin, J | 1 |
| Heutte, N | 1 |
| Vaur, D | 1 |
| Quak, E | 1 |
| Rame, JP | 1 |
| Blanchard, D | 1 |
| de Raucourt, D | 1 |
| Bardet, S | 1 |
| Williams, GR | 1 |
| Akkari, M | 1 |
| Schmitt, D | 1 |
| Jeandel, C | 1 |
| Raingeard, I | 1 |
| Blanchet, C | 1 |
| Cartier, C | 1 |
| Garrel, R | 1 |
| Guerrier, B | 1 |
| Makeieff, M | 1 |
| Mondain, M | 1 |
| Wang, LY | 1 |
| Smith, AW | 1 |
| Palmer, FL | 1 |
| Tuttle, RM | 2 |
| Mahrous, A | 1 |
| Nixon, IJ | 1 |
| Patel, SG | 1 |
| Ganly, I | 1 |
| Fagin, JA | 1 |
| Boucai, L | 1 |
| Xia, Q | 1 |
| Dong, S | 1 |
| Bian, PD | 1 |
| Wang, J | 1 |
| Li, CJ | 1 |
| Lytrivi, M | 1 |
| Kyrilli, A | 1 |
| Burniat, A | 1 |
| Ruiz Patino, M | 1 |
| Sokolow, Y | 1 |
| Corvilain, B | 1 |
| Tran, CS | 1 |
| Ben Slimène, F | 1 |
| Mhiri, A | 1 |
| Ben Ali, M | 1 |
| Slimène, H | 1 |
| Ben Raies, N | 1 |
| Karboua, E | 1 |
| Schlumberger, M | 6 |
| van der Wardt, RA | 1 |
| Persoon, AC | 1 |
| Klein Hesselink, EN | 1 |
| Links, TP | 1 |
| Mousa, U | 1 |
| Yikilmaz, AS | 1 |
| Nar, A | 1 |
| Yener, S | 1 |
| Comlekci, A | 1 |
| Arda, N | 1 |
| Men, S | 1 |
| Yesil, S | 1 |
| Gkountouvas, A | 1 |
| Thomas, D | 1 |
| Tertipi, A | 1 |
| Chrysanthou, K | 1 |
| Kaldrimidis, P | 1 |
| Chianelli, M | 1 |
| Todino, V | 1 |
| Graziano, FM | 1 |
| Panunzi, C | 1 |
| Pace, D | 1 |
| Guglielmi, R | 2 |
| Signore, A | 1 |
| Papini, E | 2 |
| Giovanella, L | 1 |
| Maffioli, M | 1 |
| Ceriani, L | 1 |
| De Palma, D | 1 |
| Spriano, G | 1 |
| Alba, M | 1 |
| Fintini, D | 1 |
| Lovicu, RM | 1 |
| Paragliola, RM | 1 |
| Papi, G | 1 |
| Rota, CA | 1 |
| Pontecorvi, A | 1 |
| Corsello, SM | 1 |
| Piccardo, A | 1 |
| Arecco, F | 1 |
| Morbelli, S | 1 |
| Bianchi, P | 1 |
| Barbera, F | 1 |
| Finessi, M | 1 |
| Corvisieri, S | 1 |
| Pestarino, E | 1 |
| Foppiani, L | 1 |
| Villavecchia, G | 1 |
| Cabria, M | 1 |
| Orlandi, F | 1 |
| Aron, M | 1 |
| Cote, V | 1 |
| Tamilia, M | 1 |
| Hier, M | 1 |
| Black, MJ | 1 |
| Zhang, X | 1 |
| Payne, RJ | 1 |
| Vera, P | 1 |
| Kuhn-Lansoy, C | 1 |
| Edet-Sanson, A | 2 |
| Hapdey, S | 1 |
| Modzelewski, R | 1 |
| Hitzel, A | 1 |
| d'Anjou, J | 1 |
| Basuyau, JP | 1 |
| Wang, TS | 1 |
| Cheung, K | 1 |
| Mehta, P | 1 |
| Roman, SA | 1 |
| Walker, HD | 1 |
| Sosa, JA | 1 |
| Negro, R | 1 |
| Pinchera, A | 2 |
| Baroli, A | 1 |
| Beck-Peccoz, P | 1 |
| Garofalo, P | 1 |
| Pisoni, MP | 1 |
| Zini, M | 1 |
| Chiovato, L | 1 |
| Hirsch, D | 1 |
| Levy, S | 1 |
| Tsvetov, G | 1 |
| Weinstein, R | 1 |
| Lifshitz, A | 1 |
| Singer, J | 1 |
| Shraga-Slutzky, I | 1 |
| Grozinski-Glasberg, S | 1 |
| Shimon, I | 1 |
| Benbassat, C | 1 |
| Kahara, T | 1 |
| Iwaki, N | 1 |
| Kaya, H | 1 |
| Kurokawa, T | 1 |
| Yoshida, T | 1 |
| Ishikura, K | 1 |
| Usuda, R | 1 |
| Konrády, A | 1 |
| Rosario, PW | 5 |
| Xavier, AC | 1 |
| Brassard, M | 1 |
| Borget, I | 1 |
| Giraudet, AL | 1 |
| Mundler, O | 1 |
| Toubeau, M | 1 |
| Bonichon, F | 1 |
| Borson-Chazot, F | 1 |
| Leenhardt, L | 1 |
| Schvartz, C | 1 |
| Dejax, C | 1 |
| Brenot-Rossi, I | 1 |
| Toubert, ME | 1 |
| Torlontano, M | 2 |
| Benhamou, E | 1 |
| Martins de Almeida, JF | 1 |
| Gonçalves Tsumura, W | 1 |
| Vaisman, M | 1 |
| Montalli Assumpção, LV | 1 |
| Ward, LS | 1 |
| Lim, JA | 1 |
| Ahn, HY | 1 |
| Kim, KW | 1 |
| Yi, KH | 1 |
| Cho, BY | 1 |
| Zhou, ZH | 1 |
| Cui, XN | 1 |
| Xing, HG | 1 |
| Yan, RH | 1 |
| Yao, DK | 1 |
| Wang, LX | 1 |
| Vita, R | 1 |
| Saraceno, G | 1 |
| Trimarchi, F | 1 |
| Benvenga, S | 1 |
| Castagna, MG | 1 |
| Brilli, L | 1 |
| Pentheroudakis, G | 1 |
| Furtado, Mde S | 1 |
| Mineiro Filho, AF | 1 |
| Lacerda, RX | 1 |
| Calsolari, MR | 1 |
| Rajkovaca, Z | 1 |
| Kovacević, P | 1 |
| Stanetić, M | 1 |
| Ristić, S | 1 |
| Czernik, E | 1 |
| Deja, R | 1 |
| Gubała, E | 1 |
| Kukulska, A | 1 |
| Turska, M | 1 |
| Dabrowska-Czuba, E | 1 |
| Bartnikowa, W | 1 |
| Jarzab, B | 1 |
| Kasner, DL | 1 |
| Spieth, ME | 1 |
| Starkman, ME | 1 |
| Zdor-North, D | 1 |
| Leboulleux, S | 1 |
| Baudin, E | 3 |
| LYONS, AR | 1 |
| EDELSTYN, GA | 1 |
| Zöphel, K | 1 |
| Wunderlich, G | 1 |
| Smith, BR | 1 |
| Giusti, M | 1 |
| Zoccola, R | 1 |
| Guazzini, B | 1 |
| Molinari, E | 2 |
| Valenti, S | 1 |
| Villa, G | 2 |
| Bertolazzi, L | 1 |
| Minuto, F | 1 |
| Golger, A | 1 |
| Fridman, TR | 1 |
| Eski, S | 2 |
| Witterick, IJ | 2 |
| Freeman, JL | 2 |
| Walfish, PG | 2 |
| Attard, M | 1 |
| Crocetti, U | 1 |
| Tumino, S | 1 |
| Bruno, R | 1 |
| Costante, G | 1 |
| D'Azzò, G | 1 |
| Meringolo, D | 1 |
| Ferretti, E | 1 |
| Sacco, R | 1 |
| Arturi, F | 1 |
| Filetti, S | 1 |
| Borges, MA | 2 |
| Fagundes, TA | 2 |
| Franco, AC | 1 |
| Purisch, S | 4 |
| Woodrum, DT | 1 |
| Gauger, PG | 1 |
| Gibelli, B | 1 |
| Tredici, P | 1 |
| De Cicco, C | 1 |
| Bodei, L | 2 |
| Sandri, MT | 1 |
| Renne, G | 1 |
| Bruschini, R | 1 |
| Tradati, N | 1 |
| Davids, T | 1 |
| Godart, V | 1 |
| Weynand, B | 1 |
| Coche, E | 1 |
| De Nayer, P | 1 |
| Daumerie, C | 1 |
| Padrão, EL | 2 |
| Rezende, LL | 2 |
| Barroso, AL | 2 |
| do Rosário, PW | 1 |
| Alves, MF | 1 |
| Lee, YH | 1 |
| Lee, NJ | 1 |
| Kim, JH | 1 |
| Song, JJ | 1 |
| Subbiah, S | 1 |
| Collins, BJ | 1 |
| Schneider, AB | 1 |
| Pelizzo, MR | 1 |
| Boschin, IM | 1 |
| Toniato, A | 1 |
| Piotto, A | 1 |
| Pagetta, C | 1 |
| Gross, MD | 1 |
| Al-Nahhas, A | 1 |
| Rubello, D | 1 |
| Santos, RB | 1 |
| Melo, TG | 1 |
| Assumpção, LV | 1 |
| Maciel, RM | 1 |
| Miyakawa, M | 1 |
| Ito, Y | 1 |
| Miyauchi, A | 1 |
| Pelttari, H | 1 |
| Laitinen, K | 1 |
| Schalin-Jäntti, C | 1 |
| Välimäki, MJ | 1 |
| Thomas, BS | 1 |
| Bulbrook, RD | 1 |
| Russell, MJ | 1 |
| Hayward, JL | 1 |
| Millis, R | 1 |
| Hartel, E | 1 |
| Erdt, A | 1 |
| Bartels, H | 1 |
| Reiners, C | 1 |
| Börner, W | 1 |
| Mariotti, S | 1 |
| Barbesino, G | 1 |
| Caturegli, P | 1 |
| Marinò, M | 1 |
| Manetti, L | 1 |
| Fugazzola, L | 1 |
| Blahd, WH | 1 |
| Pujol, P | 1 |
| Osman, A | 1 |
| Bringer, J | 1 |
| Jaffiol, C | 1 |
| Wemeau, JL | 1 |
| Obiols, G | 1 |
| Simó, R | 1 |
| Burgos, R | 1 |
| Tresserras, R | 1 |
| Galofré, P | 1 |
| Masmiquel, L | 1 |
| Hernández, C | 1 |
| Mesa, J | 1 |
| Frusciante, V | 1 |
| Carnevale, V | 1 |
| Scillitani, A | 1 |
| Zingrillo, M | 1 |
| Dicembrino, F | 1 |
| Giannatempo, GM | 1 |
| Ghiggi, MR | 1 |
| Minisola, S | 1 |
| Gallowitsch, HJ | 1 |
| Mikosch, P | 1 |
| Kresnik, E | 1 |
| Unterweger, O | 1 |
| Gomez, I | 1 |
| Lind, P | 1 |
| Travagli, JP | 2 |
| Cailleux, AF | 1 |
| Ricard, M | 1 |
| Caillou, B | 1 |
| Parmentier, C | 1 |
| Ringel, MD | 1 |
| Balducci-Silano, PL | 1 |
| Anderson, JS | 1 |
| Spencer, CA | 1 |
| Silverman, J | 1 |
| Sparling, YH | 1 |
| Francis, GL | 1 |
| Burman, KD | 1 |
| Wartofsky, L | 1 |
| Ladenson, PW | 1 |
| Levine, MA | 1 |
| Wang, PW | 1 |
| Wang, ST | 1 |
| Liu, RT | 1 |
| Chien, WY | 1 |
| Tung, SC | 1 |
| Lu, YC | 1 |
| Chen, HY | 1 |
| Lee, CH | 1 |
| Kamel, N | 1 |
| Güllü, S | 1 |
| Dağci Ilgin, S | 1 |
| Corapçioğlu, D | 1 |
| Tonyukuk Cesur, V | 1 |
| Uysal, AR | 1 |
| Başkal, N | 1 |
| Erdoğan, G | 1 |
| Schlumberger, MJ | 2 |
| Mariani, G | 1 |
| Ferdeghini, M | 1 |
| Augeri, C | 1 |
| Taddei, GZ | 1 |
| Scopinaro, G | 1 |
| Boni, G | 1 |
| Rabitti, C | 1 |
| Bianchi, R | 1 |
| Almeida-Filho, P | 1 |
| Ravizzini, GC | 1 |
| Almeida, C | 1 |
| Borges-Neto, S | 1 |
| Moog, F | 1 |
| Linke, R | 1 |
| Manthey, N | 1 |
| Tiling, R | 1 |
| Knesewitsch, P | 1 |
| Tatsch, K | 1 |
| Hahn, K | 1 |
| Torlantano, M | 1 |
| Haugen, BR | 1 |
| de Geus-Oei, LF | 1 |
| Oei, HY | 1 |
| Hennemann, G | 1 |
| Krenning, EP | 1 |
| Santen, RJ | 1 |
| Samojlik, E | 1 |
| Lipton, A | 1 |
| Harvey, H | 1 |
| Ruby, EB | 1 |
| Wells, SA | 1 |
| Kendall, J | 1 |
| Geissl, G | 1 |
| Heinze, G | 1 |
| Pickardt, CR | 1 |
| Halnan, KE | 1 |
| Visa Zueras, MT | 1 |
| Alonso Blanco, M | 1 |
| Yturriaga Matarranz, R | 1 |
| Ros Pérez, P | 1 |
| Monroy Morante, C | 1 |
| Sarriá Oses, JM | 1 |
| Barrio Castellanos, R | 1 |
| Bätge, B | 1 |
| Dralle, H | 1 |
| Padberg, B | 1 |
| von Herbay, B | 1 |
| Schröder, S | 1 |
| Degrossi, OJ | 1 |
| Rozados, IB | 1 |
| Damilano, S | 1 |
| Degrossi, EB | 1 |
| de Ganino, L | 1 |
| Pinkas, M | 1 |
| García del Río, H | 1 |
| Artagaveytía, D | 1 |
| Ross, DS | 1 |
| Harvey, RD | 1 |
| Matheson, NA | 1 |
| Grabowski, PS | 1 |
| Rodger, AB | 1 |
| Allo, MD | 1 |
| Christianson, W | 1 |
| Koivunen, D | 1 |
| Blackburn, G | 1 |
20 reviews available for thyroxine and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Novel presentation of the c.1856A > G (p.Asp619Gly) TSHR gene-activating variant: relapsing hyperthyroidism in three subsequent generations manifesting in early childhood and an in vitro functional study.
Topics: Antithyroid Agents; Child, Preschool; Graves Disease; Humans; Hyperthyroidism; Iodine Radioisotopes; | 2021 |
[Advances in postoperative thyroid-stimulating hormone suppression therapy in females with thyroid cancer].
Topics: Adenocarcinoma; Disease Progression; Female; Humans; Hypothyroidism; Neoplasm Recurrence, Local; Pos | 2018 |
Advances in the management of differentiated thyroid cancer with follicular cell strain.
Topics: Adenocarcinoma, Follicular; Hormone Replacement Therapy; Humans; Iodine Radioisotopes; Neoplasm Recu | 2016 |
[Differentiated thyroid cancer -- 2009].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Fine-Needle; Carcinoma; Carcinoma, Medullary | 2011 |
Follow-up of differentiated thyroid cancer.
Topics: Adenocarcinoma, Follicular; Autoantibodies; Biomarkers, Tumor; Carcinoma, Papillary; Combined Modali | 2002 |
Follow-up of thyroid cancer patients with favorable prognostic indicators.
Topics: Adenocarcinoma, Follicular; Carcinoma, Papillary; Follow-Up Studies; Humans; Iodine Radioisotopes; N | 2003 |
Role of 131I in the treatment of well differentiated thyroid cancer.
Topics: Adenocarcinoma, Follicular; Antineoplastic Agents, Hormonal; Carcinoma, Papillary; Combined Modality | 2005 |
[Recombinant TSH in ablative therapy and follow-up of patients with differentiated thyroid carcinoma].
Topics: Carcinoma; Follow-Up Studies; Humans; Hypothyroidism; Iodine Radioisotopes; Neoplasm Recurrence, Loc | 2005 |
[Familial nommedullary thyroid cancer].
Topics: Adenocarcinoma, Follicular; Age Factors; Carcinoma, Papillary; Early Diagnosis; Female; Genetic Pred | 2007 |
[Will the thyroglobulin assay with lower functional sensitivity whilst the patients are on L-T4 treatment replace the TSH-stimulated thyroglobulin assay in the follow-up of patients with differentiated thyroid cancer?].
Topics: Algorithms; Biological Assay; Carcinoma; Humans; Neoplasm Recurrence, Local; Neoplasm, Residual; Pra | 2007 |
[Effects of thyrotropin-suppressive therapy in patients with well-differentiated thyroid carcinoma].
Topics: Atrial Fibrillation; Chemotherapy, Adjuvant; Humans; Hyperthyroidism; Neoplasm Recurrence, Local; Os | 2007 |
Appropriate treatment for asymptomatic papillary microcarcinoma of the thyroid.
Topics: Carcinoma, Papillary; Humans; Incidental Findings; Lymph Node Excision; Lymphatic Metastasis; Neopla | 2007 |
Management of thyroid cancer.
Topics: Animals; Cattle; Combined Modality Therapy; Humans; Iodine Radioisotopes; Neoplasm Recurrence, Local | 1993 |
[Suppressive hormonal therapy for thyroid nodule. Theoretical bases and practical modalities].
Topics: Combined Modality Therapy; Humans; Neoplasm Recurrence, Local; Thyroid Nodule; Thyroxine | 1997 |
Diagnostic follow-up of well-differentiated thyroid carcinoma: historical perspective and current status.
Topics: Adenocarcinoma, Follicular; Carcinoma, Papillary; Humans; Neoplasm Metastasis; Neoplasm Recurrence, | 1999 |
Papillary and follicular thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Carcinoma, Papillary; Humans; Iodine Radioisotopes; Neoplasm Metastasis; | 2000 |
Initial treatment of differentiated thyroid carcinoma.
Topics: Humans; Iodine Radioisotopes; Neoplasm Recurrence, Local; Neoplasm Staging; Risk Factors; Thyroid Ne | 2000 |
Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer.
Topics: Adrenocorticotropic Hormone; Aldosterone; Aminoglutethimide; Androstenedione; Breast Neoplasms; Dehy | 1977 |
[Differentiated thyroid carcinoma in childhood].
Topics: Adenocarcinoma; Age Factors; Child; Child, Preschool; Female; Humans; Male; Neoplasm Recurrence, Loc | 1992 |
Long-term management of differentiated thyroid cancer.
Topics: Biopsy, Needle; Female; Humans; Iodine Radioisotopes; Male; Neoplasm Recurrence, Local; Radionuclide | 1990 |
6 trials available for thyroxine and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Feasibility study on individualized management of postoperative patients with differentiated thyroid cancer based on internet and programming technology.
Topics: Adenocarcinoma; Feasibility Studies; Humans; Internet; Neoplasm Recurrence, Local; Quality of Life; | 2023 |
Serum fetuin-A levels following recombinant human thyroid-stimulating hormone stimulation.
Topics: Adult; alpha-2-HS-Glycoprotein; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Thyro | 2013 |
Low-activity (2.0 GBq; 54 mCi) radioiodine post-surgical remnant ablation in thyroid cancer: comparison between hormone withdrawal and use of rhTSH in low-risk patients.
Topics: Adult; Aged; Female; Follow-Up Studies; Humans; Hypothyroidism; Iodine Radioisotopes; Male; Middle A | 2009 |
A novel formulation of L-thyroxine (L-T4) reduces the problem of L-T4 malabsorption by coffee observed with traditional tablet formulations.
Topics: Adult; Antithyroid Agents; Capsules; Chemistry, Pharmaceutical; Coffee; Cross-Over Studies; Drug Car | 2013 |
Follow-up of low risk patients with papillary thyroid cancer: role of neck ultrasonography in detecting lymph node metastases.
Topics: Adolescent; Adult; Biopsy; Carcinoma, Papillary; Cohort Studies; Drug Administration Schedule; Femal | 2004 |
Global skeletal uptake of technetium-99m methylene diphosphonate in female patients receiving suppressive doses of L-thyroxine for differentiated thyroid cancer.
Topics: Absorptiometry, Photon; Adult; Biomarkers; Bone and Bones; Bone Density; Female; Follow-Up Studies; | 1998 |
85 other studies available for thyroxine and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Thyroid Hormones and Morphological Features of Primary Breast Cancer.
Topics: Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Carcinoma in Situ; Cell Proliferation; Female; Hum | 2022 |
RESULTS OF THE ANALYSIS OF ONCOLOGICAL COMPLICATIONS OF ANTI-TUMOR TREATMENT IN PATIENTS WITH THYROID CANCER ON THE BASIS OF MATHEMATICAL ANALYSIS OF THE CATAMNESTIC DATA.
Topics: Female; Humans; Iodine Radioisotopes; Neoplasm Recurrence, Local; Thyroid Function Tests; Thyroid Ne | 2022 |
Combined prognostic value of preoperative serum thyrotrophin and thyroid hormone concentration in papillary thyroid cancer.
Topics: Humans; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Risk Factors; Thyroid Cancer, | 2022 |
The effect of non-oncology drugs on clinical and genomic risk in early luminal breast cancer.
Topics: Breast Neoplasms; Female; Genomics; Humans; Metformin; Neoplasm Recurrence, Local; Thyroxine | 2022 |
The effect of non-oncology drugs on clinical and genomic risk in early luminal breast cancer.
Topics: Breast Neoplasms; Female; Genomics; Humans; Metformin; Neoplasm Recurrence, Local; Thyroxine | 2022 |
The effect of non-oncology drugs on clinical and genomic risk in early luminal breast cancer.
Topics: Breast Neoplasms; Female; Genomics; Humans; Metformin; Neoplasm Recurrence, Local; Thyroxine | 2022 |
The effect of non-oncology drugs on clinical and genomic risk in early luminal breast cancer.
Topics: Breast Neoplasms; Female; Genomics; Humans; Metformin; Neoplasm Recurrence, Local; Thyroxine | 2022 |
Postoperative hypothalamic-pituitary dysfunction and long-term hormone replacement in patients with childhood-onset craniopharyngioma.
Topics: Child; Craniopharyngioma; Deamino Arginine Vasopressin; Hormone Replacement Therapy; Humans; Hydroco | 2023 |
Oncological impact of hypothyroidism and levothyroxine supplementation following hemithyroidectomy in patients with papillary thyroid carcinoma.
Topics: Dietary Supplements; Humans; Hypothyroidism; Neoplasm Recurrence, Local; Retrospective Studies; Thyr | 2020 |
Influence of Tumor Number on Clinicopathologic Features and Outcomes of Patients With Papillary Thyroid Carcinoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Humans; Iodine Radioisotopes; Lymph Nodes; Lymph | 2020 |
Thyroid Hormones, Silencing Mediator for Retinoid and Thyroid Receptors and Prognosis in Primary Breast Cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Disease-Free Survival; Female; | 2020 |
Association of tumor size and focality with recurrence/persistence in papillary thyroid cancer patients treated with total thyroidectomy along with radioactive-iodine ablation and TSH suppression.
Topics: Adolescent; Adult; Aged; Carcinoma, Papillary; Disease-Free Survival; Female; Follow-Up Studies; Hum | 2018 |
Video-Assisted Thyroidectomy for Papillary Thyroid Carcinoma: Oncologic Outcome in Patients with Follow-Up ≥ 10 Years.
Topics: Adolescent; Adult; Aged; Carcinoma; Carcinoma, Papillary; Female; Follow-Up Studies; Humans; Iodine | 2018 |
Long-term sequelae of the less than total thyroidectomy procedures for benign thyroid nodular disease.
Topics: Aged; Female; Follow-Up Studies; Goiter, Nodular; Humans; Hyperthyroidism; Male; Middle Aged; Neopla | 2019 |
Postoperative Thyroid-Stimulating Hormone Levels Did Not Affect Recurrence after Thyroid Lobectomy in Patients with Papillary Thyroid Cancer.
Topics: Adult; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Postoperative Period; Risk Fac | 2019 |
[Clinical significance of three-week thyroglobulin test in patients with thyroid cancer undergoing thyroidectomy].
Topics: Adult; Aged; Biomarkers, Tumor; Female; Hormone Replacement Therapy; Humans; Male; Middle Aged; Neop | 2012 |
Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up.
Topics: Adult; Combined Modality Therapy; Disease-Free Survival; Female; Follow-Up Studies; Humans; Iodine R | 2013 |
Unilateral thyroidectomy for the treatment of benign multinodular goiter.
Topics: Adult; Aged; Databases, Factual; Female; Follow-Up Studies; Goiter, Nodular; Humans; Male; Middle Ag | 2013 |
Hypothyroidism after radiotherapy of head and neck cancer.
Topics: Aged; Carcinoma; Carcinoma, Squamous Cell; Dose Fractionation, Radiation; Female; Follow-Up Studies; | 2014 |
Risk factors for recurrence after therapeutic lateral neck dissection for primary papillary thyroid cancer.
Topics: Adult; Aged; Area Under Curve; Autoantibodies; Carcinoma, Papillary; Disease-Free Survival; Female; | 2014 |
Stimulated thyroglobulin level at ablation in differentiated thyroid cancer: the impact of treatment preparation modalities and tumor burden.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Carcinoma; Carcinoma, Papillary; Female; Humans; Iodine Rad | 2014 |
Is prophylactic anti-resorptive therapy required in thyroid cancer patients receiving TSH-suppressive treatment with thyroxine?
Topics: Bone and Bones; Bone Density Conservation Agents; Combined Modality Therapy; Dose-Response Relations | 2014 |
Nodular recurrence and hypothyroidism following partial thyroidectomy for benign nodular thyroid disease in children and adolescents.
Topics: Adolescent; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Hypothyroidism; Male; Neopla | 2014 |
Thyrotropin suppression increases the risk of osteoporosis without decreasing recurrence in ATA low- and intermediate-risk patients with differentiated thyroid carcinoma.
Topics: Adult; Aged; Bone and Bones; Disease-Free Survival; Female; Follow-Up Studies; Humans; Male; Middle | 2015 |
Effects of endocrine therapy on the prognosis of elderly patients after surgery for papillary thyroid carcinoma.
Topics: Aged; Aged, 80 and over; Carcinoma; Carcinoma, Papillary; China; Female; Hormone Replacement Therapy | 2016 |
Thyroid lobectomy is an effective option for unilateral benign nodular disease.
Topics: Adult; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Ret | 2016 |
Thyroid-stimulating hormone acutely increases monocyte gene expression in vivo.
Topics: Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Monocytes; Neoplasm Recurrence, Local; Reco | 2016 |
Long-Term Follow-Up for Differentiated Thyroid Carcinoma Patients: A Reconsideration.
Topics: Aftercare; Cohort Studies; Combined Modality Therapy; Follow-Up Studies; Hormone Replacement Therapy | 2017 |
Stimulated thyroglobulin values above 5.6 ng/ml before radioactive iodine ablation treatment following levothyroxine withdrawal is associated with a 2.38-fold risk of relapse in Tg-ab negative subjects with differentiated thyroid cancer.
Topics: Adenocarcinoma, Follicular; Autoantibodies; Carcinoma, Papillary; Catheter Ablation; Female; Follow- | 2017 |
Misdiagnosis due to the hook effect in prolactin assay.
Topics: Antineoplastic Agents; Cabergoline; Diabetes Insipidus, Neurogenic; Diagnostic Errors; Ergolines; Fe | 2008 |
Exophytic and ulcerated local recurrence of papillary thyroid carcinoma with spectacular response to external beam radiotherapy.
Topics: Carcinoma, Papillary; Female; Goiter; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Midd | 2008 |
Unstimulated high sensitive thyroglobulin measurement predicts outcome of differentiated thyroid carcinoma.
Topics: Adult; Aged; Carcinoma; Female; Humans; Immunoradiometric Assay; Male; Middle Aged; Neoplasm Recurre | 2009 |
Levothyroxine therapy in preventing nodular recurrence after hemithyroidectomy: a retrospective study.
Topics: Female; Goiter, Nodular; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studie | 2009 |
Low thyroglobulin concentrations after thyroidectomy increase the prognostic value of undetectable thyroglobulin levels on levo-thyroxine suppressive treatment in low-risk differentiated thyroid cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; | 2010 |
Ablative free thyroxine to thyroglobulin ratio as a predictor of differentiated thyroid cancer recurrence.
Topics: Adult; Aged; Biomarkers, Tumor; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Retro | 2009 |
Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Child; | 2010 |
To stimulate or withdraw? A cost-utility analysis of recombinant human thyrotropin versus thyroxine withdrawal for radioiodine ablation in patients with low-risk differentiated thyroid cancer in the United States.
Topics: Adult; Cost-Benefit Analysis; Costs and Cost Analysis; Decision Support Techniques; Decision Trees; | 2010 |
Thyroid nodule and differentiated thyroid cancer management in pregnancy. An Italian Association of Clinical Endocrinologists (AME) and Italian Thyroid Association (AIT) Joint Statement for Clinical Practice.
Topics: Biopsy, Fine-Needle; Deficiency Diseases; Female; Humans; Iodine; Neoplasm Recurrence, Local; Pregna | 2010 |
Impact of pregnancy on outcome and prognosis of survivors of papillary thyroid cancer.
Topics: Adenocarcinoma, Papillary; Adult; Disease Progression; Female; Follow-Up Studies; Humans; Neoplasm R | 2010 |
Transition of thyroid autoantibodies by rituximab treatment for thyroid MALT lymphoma.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclop | 2011 |
Recombinant human thyroid stimulating hormone in thyroid remnant ablation with 1.1 GBq 131iodine in low-risk patients.
Topics: Adult; Aged; Autoantibodies; Biopsy, Fine-Needle; Drug Administration Schedule; Female; Follow-Up St | 2012 |
Long-term follow-up of patients with papillary and follicular thyroid cancer: a prospective study on 715 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Autoantibodies; Carcinoma, Papillary, Follicular; Cohort | 2011 |
Current recommendations for levothyroxine treatment of differentiated thyroid cancer patients are not properly implemented in clinical practice.
Topics: Biomarkers, Tumor; Cell Differentiation; Choice Behavior; Female; Follow-Up Studies; Humans; Male; M | 2012 |
Serum thyroglobulin level measured after thyroxine withdrawal is useful to predict further recurrence in whole body scan-negative papillary thyroid cancer patients after reoperation.
Topics: Adult; Aged; Carcinoma; Carcinoma, Papillary; Female; Humans; Male; Middle Aged; Neck; Neoplasm Recu | 2012 |
Changes and prognostic value of serum vascular endothelial growth factor in patients with differentiated thyroid cancer.
Topics: Adolescent; Adult; Age Factors; Aged; Female; Humans; Lung Neoplasms; Male; Medication Adherence; Mi | 2013 |
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Topics: Antineoplastic Agents; Carcinoma, Medullary; Carcinoma, Papillary; Combined Modality Therapy; Humans | 2012 |
Value of diagnostic radioiodine whole-body scanning after initial therapy in patients with differentiated thyroid cancer at intermediate and high risk for recurrence.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Humans; Iodine Radioisotopes; Lymphatic M | 2012 |
[Assessment of recombinant human thyrotropin application in following-up patients with well-differentiated thyroid carcinoma].
Topics: Adult; Aged; Carcinoma, Papillary; Hormone Replacement Therapy; Humans; Iodine Radioisotopes; Male; | 2012 |
[Comparison of efficacy of various methods of thyroglobulin measurements in differentiated thyroid cancer].
Topics: Biomarkers; Humans; Immunoradiometric Assay; Monitoring, Physiologic; Neoplasm Recurrence, Local; Th | 2001 |
Thyroid carcinoma: iodine-131-negative whole-body scan reverses to positive after a combination of thyrogen stimulation and withdrawal.
Topics: Adenocarcinoma, Follicular; Carcinoma, Papillary; False Negative Reactions; Female; Head and Neck Ne | 2002 |
THYROID HORMONE AS A PROPHYLACTIC AGENT FOLLOWING RADICAL TREATMENT OF BREAST CANCER.
Topics: Breast Neoplasms; Drug Therapy; Humans; Mastectomy; Neoplasm Metastasis; Neoplasm Recurrence, Local; | 1965 |
Serum thyroglobulin measurements with a high sensitivity enzyme-linked immunosorbent assay: is there a clinical benefit in patients with differentiated thyroid carcinoma?
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Enzyme | 2003 |
Recombinant human TSH changes the multidisciplinary approach to patients with differentiated thyroid carcinoma. Two-year experience.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Cohort Studies; Female; Follow-Up Studies; Hor | 2003 |
Three-week thyroxine withdrawal thyroglobulin stimulation screening test to detect low-risk residual/recurrent well-differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Carcinoma, Papillary; Cohort Studies; Drug Administra | 2003 |
Is stimulation of thyroglobulin (Tg) useful in low-risk patients with thyroid carcinoma and undetectable Tg on thyroxin and negative neck ultrasound?
Topics: Humans; Neoplasm Recurrence, Local; Recombinant Proteins; Risk Assessment; Thyroglobulin; Thyroid Ne | 2005 |
Is stimulation of thyroglobulin (Tg) useful in low-risk patients with thyroid carcinoma and undetectable Tg on thyroxin and negative neck ultrasound?
Topics: Adult; Aged; Antibodies, Monoclonal; Female; Follow-Up Studies; Humans; Iodine Radioisotopes; Lympha | 2005 |
Preoperative determination of serum thyroglobulin to identify patients with differentiated thyroid cancer who may present recurrence without increased thyroglobulin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Female; Humans; Male; Middle Aged; | 2005 |
Three-week thyroxine withdrawal: a thyroid-specific quality of life study.
Topics: Adolescent; Adult; Aged; Female; Humans; Hypothyroidism; Iodine Radioisotopes; Male; Mass Screening; | 2006 |
Intense 18-fluorodeoxyglucose uptake by the thymus on PET scan does not necessarily herald recurrence of thyroid carcinoma.
Topics: Adult; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm | 2005 |
[Follow-up of high-risk patients with differentiated thyroid cancer without persistent disease after initial therapy].
Topics: Adenocarcinoma, Follicular; Carcinoma, Papillary; Catheter Ablation; Continuity of Patient Care; Fem | 2006 |
US diagnosis of cervical recurrence in patients operated on thyroid cancer: sonographic features and clinical significance.
Topics: Adult; Aged; Autoantibodies; Biomarkers, Tumor; Biopsy, Fine-Needle; Female; Follow-Up Studies; Huma | 2007 |
Factors related to the recurrence of thyroid nodules after surgery for benign radiation-related nodules.
Topics: Adult; Child; Child, Preschool; Cohort Studies; Female; Follow-Up Studies; Humans; Infant; Kaplan-Me | 2007 |
Papillary thyroid carcinoma: 35-year outcome and prognostic factors in 1858 patients.
Topics: Adenocarcinoma, Papillary; Adult; Analysis of Variance; Chi-Square Distribution; Combined Modality T | 2007 |
Does a highly sensitive thyroglobulin (Tg) assay change the clinical management of low-risk patients with thyroid cancer with Tg on T4 < 1 ng/ml determined by traditional assays?
Topics: Adolescent; Adult; Aged; Clinical Laboratory Techniques; Disease Management; Female; Humans; Male; M | 2008 |
Long-term outcome of 495 TNM stage I or II patients with differentiated thyroid carcinoma followed up with neck ultrasonography and thyroglobulin measurements on T4 treatment.
Topics: Adolescent; Adult; Aged; Carcinoma; Cell Differentiation; Child; Female; Follow-Up Studies; Hormone | 2008 |
Thyroid function in early breast cancer.
Topics: Adult; Aged; Androsterone; Breast Neoplasms; Etiocholanolone; Female; Humans; Mastectomy; Middle Age | 1983 |
[Recurrence prophylaxis after surgical treatment of endothoracic struma].
Topics: Choristoma; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Thoracic Neoplasms; Thyro | 1981 |
[Specific follow-up program for thyroid cancer].
Topics: Carcinoma; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Postoperative Care; Radionuclide | 1982 |
Serum soluble interleukin 2 (IL-2) receptor (sIL-2R) in differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma, Papillary; En | 1994 |
Prevention of thyroid neoplasm recurrence with Triac and levothyroxine.
Topics: Carcinoma; Drug Therapy, Combination; Humans; Neoplasm Recurrence, Local; Thyroid Neoplasms; Thyroxi | 1997 |
[Differentiated thyroid carcinoma, 1972-1992. Follow-up, detection of recurrences and prognostic factors].
Topics: Adenocarcinoma, Follicular; Adult; Carcinoma, Papillary; Combined Modality Therapy; Female; Humans; | 1997 |
Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Carcinoma, Papillary; Case-Control Studies; Combined Modality Therapy; F | 1998 |
Combination of radioiodine (131I) and probe-guided surgery for persistent or recurrent thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Carcinoma, Papillary; Female; Humans; Iodine Radioisotopes; Lymph Node E | 1998 |
[Papillary and follicular cancers of the thyroid].
Topics: Carcinoma, Papillary, Follicular; Follow-Up Studies; Humans; Iodine Radioisotopes; Lymph Node Excisi | 1998 |
Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Autoantibodies; Carcinoma, Papillary; Female; Humans; Immunoassay; Iodin | 1999 |
Levothyroxine suppression of thyroglobulin in patients with differentiated thyroid carcinoma.
Topics: Adult; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Thyroglo | 1999 |
Degree of thyrotropin suppression in differentiated thyroid cancer without recurrence or metastases.
Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Humans; Middle Aged; Neoplasm Metastasis; | 1999 |
Clinical experience with recombinant human thyrotrophin (rhTSH) in the management of patients with differentiated thyroid cancer.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Algorithms; Antineoplastic Agents, Hormonal; Bi | 2000 |
Whole-body Tc-99m sestamibi scintigraphy in the follow-up of differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adult; Biomarkers, Tumor; Carcinoma; Carcinoma, Papillary; Female; Follo | 2000 |
Influence of thyroid-stimulating hormone levels on uptake of FDG in recurrent and metastatic differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Aged; Aged, 80 and over; Carcinoma, Papillary; Female; Fluorodeoxyglucos | 2000 |
Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; False | 2002 |
[TSH state after thyroid hormone deprivation in athyrotic thyroid cancer patients (author's transl)].
Topics: Female; Humans; Hypothyroidism; Iodine; Iodine Radioisotopes; Male; Neoplasm Metastasis; Neoplasm Re | 1977 |
The non-surgical treatment of thyroid cancer.
Topics: Adenocarcinoma; Age Factors; Aged; Calcitonin; Carcinoma, Papillary; Cell Count; Cell Survival; Chil | 1975 |
Histology and immunocytochemistry of differentiated thyroid carcinomas do not predict radioiodine uptake: a clinicomorphological study of 62 recurrent or metastatic tumours.
Topics: Adenocarcinoma; Humans; Iodine Radioisotopes; Neoplasm Metastasis; Neoplasm Recurrence, Local; Thyro | 1992 |
[Serum thyroglobulin and whole-body scanning as markers in the follow-up of differentiated thyroid carcinomas].
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Biomarkers, Tumor; Carcinoma, Papillary; Female; Follow-Up | 1991 |
Measurement of serum thyroglobulin is of value in detecting tumour recurrence following treatment of differentiated thyroid carcinoma by lobectomy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma; Female; Humans; Male; Middle | 1990 |
Not all "occult" papillary carcinomas are "minimal".
Topics: Adult; Carcinoma, Papillary; Combined Modality Therapy; Female; Humans; Iodine Radioisotopes; Lympha | 1988 |
Carcinoma of the thyroid.
Topics: Adenocarcinoma; Adult; Carcinoma; Carcinoma, Papillary; Child; Female; Humans; Iodine Isotopes; Male | 1969 |